Sign Out
Overdosage in humans may result in a prolonged duration of action but is unlikely to be associated with acute toxic effects.
Non-specific toxic symptoms were observed in rodents after intraperitoneal administration of cetrorelix doses more than 200 times higher than the pharmacologically effective dose after subcutaneous administration.
Continue with Google